• OPEN AN ACCOUNT
Indian Indices
Sensex
73,580.54 -1,247.71
( -1.67%)
Global Indices
Nasdaq
51,527.73 -356.96
(-0.69%)
Dow Jones
7,726.85 -58.79
(-0.76%)
Hang Seng
65,657.92 638.97
(0.98%)
Nikkei 225
10,680.49 -24.77
(-0.23%)
Forex
USD-INR
95.65 -0.17
(-0.17%)
EUR-INR
109.56 -0.37
(-0.34%)
GBP-INR
127.74 -0.44
(-0.34%)
JPY-INR
0.61 0.00
(-0.29%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
132.2958859
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
46.04
48729.65
EPS(TTM)
Face Value()
Div & Yield %
62.48
10
1.98
 

M&M production rises 20% YoY in July 2026
Aug 11,2026
The auto major's total sales stood at 1,02,710 units in July 2026, registering a growth of 24.80% on a YoY basis, while exports rose 47.43% YoY to 4,159 units in July 2026.

Mahindra & Mahindra (M&M) Group enjoys a leadership position in farm equipment, utility vehicles, information technology, and financial services in India. It is the world's largest tractor company by volume. It has a strong presence in renewable energy, agriculture, logistics, hospitality, and real estate.

The company’s consolidated net profit climbed 33.58% to Rs 5,454.54 crore on 27.8% increase in revenue from operations to Rs 58,187.57 crore in Q1 FY27 over Q1 FY26.

Shares of Mahindra & Mahindra shed 0.03% to Rs 3,508.10 on the BSE.